• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数保留的心力衰竭患者或高血压性心脏病患者在平板运动前后的临床生化指标变化。

Changes in clinical biochemical indexes of patients with heart failure with preserved ejection fraction or patients with hypertensive heart disease before and after treadmill exercise.

作者信息

Yang Xiyan, Xing Yu, Li Kuibao

机构信息

Heart Center, Beijing Chaoyang Hospital, Capital Medical University & Beijing Key Laboratory of Hypertension, Beiing, China.

出版信息

Ann Palliat Med. 2021 Jul;10(7):7970-7976. doi: 10.21037/apm-21-1361.

DOI:10.21037/apm-21-1361
PMID:34353083
Abstract

BACKGROUND

The incidence of hypertension is continuously increasing. This study aimed to investigate the changes in clinical biochemical indexes of patients with heart failure with preserved ejection fraction (HFpEF), or patients with hypertensive heart disease (HHD) before and after treadmill exercise.

METHODS

Seventy-eight patients with HFpEF and 78 patients with HHD who were admitted to our hospital between February 2020 and February 2021 were selected to take a treadmill exercise test. All patients continued to exercise for 1 month. Clinical biochemical indexes [hemoglobin A1c (HbA1c), low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), total cholesterol (TC), N-segment pro-brain natriuretic peptide (NT-proBNP), and cardiac troponin I (cTnI)] were measured before and after the treadmill exercise test and compared between the two groups. Receiver operating characteristic (ROC) curves were drawn to analyze the optimal cutoff values of the clinical biochemical indexes in the diagnosis of HFpEF. The positive diagnostic rates of the biochemical indicators for HFpEF before and after treadmill exercise were compared using the optimal cut-off value of ROC as the positive standard.

RESULTS

Before exercise, there was no significant difference in HbA1c, LDL-C, HDL-C, or TC between the two groups (P>0.05), but NT-proBNP and cTnI were significantly higher in the HFpEF group than in the HHD group (P<0.05). ROC curve analysis showed that before exercise, the best cutoff values for plasma NT-proBNP and cTnI in the diagnosis of HFpEF were 2,248.24 pg/mL and 1.14 ng/mL, respectively. After exercise, no significant difference was found in HbA1c, LDL-C, HDL-C, or TC between the two groups (P>0.05). However, the levels of NT-proBNP and cTnI in both groups were higher after exercise, with more significant increases seen in the HFPEF group (P<0.05). The positive rates of plasma NT-proBNP and cTnI in HFpEF group were statistically higher after exercise than before exercise (P<0.05).

CONCLUSIONS

The changes in plasma NT-proBNP and cTnI in patient after treadmill exercise can be used as sensitive indicators for the diagnosis and differentiation of HFpEF and HHD.

摘要

背景

高血压的发病率持续上升。本研究旨在调查射血分数保留的心力衰竭(HFpEF)患者或高血压性心脏病(HHD)患者在平板运动前后临床生化指标的变化。

方法

选取2020年2月至2021年2月期间我院收治的78例HFpEF患者和78例HHD患者进行平板运动试验。所有患者持续运动1个月。在平板运动试验前后测量临床生化指标[糖化血红蛋白(HbA1c)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)、总胆固醇(TC)、N末端脑钠肽前体(NT-proBNP)和心肌肌钙蛋白I(cTnI)],并在两组之间进行比较。绘制受试者工作特征(ROC)曲线,分析临床生化指标在HFpEF诊断中的最佳截断值。以ROC的最佳截断值为阳性标准,比较平板运动前后HFpEF生化指标的阳性诊断率。

结果

运动前,两组患者的HbA1c、LDL-C、HDL-C或TC无显著差异(P>0.05),但HFpEF组的NT-proBNP和cTnI显著高于HHD组(P<0.05)。ROC曲线分析显示,运动前,血浆NT-proBNP和cTnI诊断HFpEF的最佳截断值分别为2248.24 pg/mL和1.14 ng/mL。运动后,两组患者的HbA1c、LDL-C、HDL-C或TC无显著差异(P>0.05)。然而,两组运动后的NT-proBNP和cTnI水平均升高,HFPEF组升高更显著(P<0.05)。HFpEF组运动后血浆NT-proBNP和cTnI的阳性率在统计学上高于运动前(P<0.05)。

结论

平板运动后患者血浆NT-proBNP和cTnI的变化可作为HFpEF和HHD诊断及鉴别的敏感指标。

相似文献

1
Changes in clinical biochemical indexes of patients with heart failure with preserved ejection fraction or patients with hypertensive heart disease before and after treadmill exercise.射血分数保留的心力衰竭患者或高血压性心脏病患者在平板运动前后的临床生化指标变化。
Ann Palliat Med. 2021 Jul;10(7):7970-7976. doi: 10.21037/apm-21-1361.
2
[Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].N末端B型利钠肽对射血分数保留的心力衰竭患者全因死亡率的预后价值
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Nov 24;47(11):875-881. doi: 10.3760/cma.j.issn.0253-3758.2019.11.005.
3
Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.生长分化因子 15、ST2、高敏肌钙蛋白 T 和 N 末端脑利钠肽前体在射血分数保留型与降低型心力衰竭中的比较。
Eur J Heart Fail. 2012 Dec;14(12):1338-47. doi: 10.1093/eurjhf/hfs130. Epub 2012 Aug 5.
4
Application Value of Systemic Inflammatory Indexes in the Clinical Evaluation of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF).系统性炎症指标在射血分数保留型心力衰竭(HFpEF)患者临床评估中的应用价值。
Medicina (Kaunas). 2022 Oct 17;58(10):1473. doi: 10.3390/medicina58101473.
5
Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.生长分化因子 15 在射血分数保留型与降低型心力衰竭中的作用。
Eur J Heart Fail. 2016 Jan;18(1):81-8. doi: 10.1002/ejhf.431. Epub 2015 Oct 25.
6
Renal function, N-terminal Pro-B-Type natriuretic peptide, propeptide big-endothelin and patients with heart failure and preserved ejection fraction.肾功能、N 末端 pro-B 型利钠肽、前内皮素原肽和射血分数保留心力衰竭患者。
Peptides. 2019 Jan;111:112-117. doi: 10.1016/j.peptides.2018.04.003. Epub 2018 Apr 21.
7
Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction.N 端脑利钠肽前体在射血分数保留型、中间范围型和降低型心力衰竭中的相关性及其预后和鉴别诊断作用。
J Card Fail. 2018 Jun;24(6):365-374. doi: 10.1016/j.cardfail.2018.03.010. Epub 2018 Mar 27.
8
Serum NT-proBNP and TUG1 as novel biomarkers for elderly hypertensive patients with heart failure with preserved ejection fraction.血清N末端B型利钠肽原和TUG1作为射血分数保留的老年高血压心力衰竭患者的新型生物标志物。
Exp Ther Med. 2021 May;21(5):446. doi: 10.3892/etm.2021.9874. Epub 2021 Mar 1.
9
Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.用于心力衰竭特征描述的生物标志物——射血分数保留型与射血分数降低型心力衰竭的鉴别
Int J Cardiol. 2017 Jan 15;227:272-277. doi: 10.1016/j.ijcard.2016.11.110. Epub 2016 Nov 9.
10
Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.射血分数保留与降低的心衰患者的预后和 NT-proBNP。
Heart. 2019 Aug;105(15):1182-1189. doi: 10.1136/heartjnl-2018-314173. Epub 2019 Apr 8.

引用本文的文献

1
The Link Between High Sensitivity Troponin T Levels and Outcomes Among Patients with Congestive Heart Failure: A Systematic Review and Meta-Analysis Study.高敏肌钙蛋白T水平与充血性心力衰竭患者预后的关联:一项系统评价与荟萃分析研究
Iran J Pathol. 2025 Summer;20(3):245-256. doi: 10.30699/ijp.2025.2057561.3440. Epub 2025 Jul 1.
2
Vericiguat on C-reactive Protein Level and Prognosis in Patients with Hypertensive Heart Failure.维立西呱对高血压性心力衰竭患者 C 反应蛋白水平和预后的影响。
High Blood Press Cardiovasc Prev. 2024 Sep;31(5):485-492. doi: 10.1007/s40292-024-00664-y. Epub 2024 Aug 22.
3
A review of cardiac troponin I detection by surface enhanced Raman spectroscopy: Under the spotlight of point-of-care testing.
表面增强拉曼光谱法检测心肌肌钙蛋白I的综述:即时检测的焦点
Front Chem. 2022 Oct 13;10:1017305. doi: 10.3389/fchem.2022.1017305. eCollection 2022.